PP
SVA

PDT Partners’s Sinovac Biotech, Ltd SVA Stock Holding History

PDT Partners’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,084
Closed -$84K – 653
2016
Q1 		$84K Hold
13,084
– – 0.01% 545
2015
Q4 		$75K Sell
13,084
-13,616
-51% -$73.3K 0.01% 381
2015
Q3 		$136K Buy
26,700
+3,400
+15% +$18K ﹤0.01% 1201
2015
Q2 		$122K Buy
23,300
+13,000
+126% +$68.7K ﹤0.01% 1287
2015
Q1 		$51K Buy
+10,300
New +$50.7K ﹤0.01% 1341
2014
Q1 		– Sell
-12,000
Closed -$73K – 1438
2013
Q4 		$73K Sell
12,000
-2,300
-16% -$13.9K 0.01% 613
2013
Q3 		$86K Buy
+14,300
New +$68.4K ﹤0.01% 1454

Other funds holding SVA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PDT Partners's SVA Position: Q2 2016 in Review

PDT Partners sold out of Sinovac Biotech, Ltd (SVA) in Q2 2016, closing a stake of 13,084 shares — an estimated $84K sold.

PDT Partners first reported a position in SVA in Q3 2013 and held it in 7 quarters. The position peaked at $136K in Q3 2015. 37 funds tracked by Wall St. Rank hold SVA as of Q2 2016.

  • PDT Partners reported no remaining Sinovac Biotech, Ltd position as of Q2 2016 after selling out during the quarter.
  • PDT Partners sold 13,084 Sinovac Biotech, Ltd shares in Q2 2016, an estimated $84K.
  • PDT Partners first reported a position in Sinovac Biotech, Ltd in Q3 2013 and held it in 7 quarters.
  • PDT Partners's Sinovac Biotech, Ltd position peaked at $136K in Q3 2015.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2016.

Based on PDT Partners's 13F filing for Q2 2016, filed 15 Aug 2016.